Immunotherapy for atherosclerosis by targeting pro-inflammatory T cells.
作者信息
Khan Amir, Ley Klaus
机构信息
Immunology Center of Georgia, Augusta University, Augusta, GA, USA.
出版信息
Cell Res. 2024 Jul;34(7):467-468. doi: 10.1038/s41422-024-00955-y.
Abstract
摘要
相似文献
1
Immunotherapy for atherosclerosis by targeting pro-inflammatory T cells.通过靶向促炎T细胞进行动脉粥样硬化的免疫治疗。
Cell Res. 2024 Jul;34(7):467-468. doi: 10.1038/s41422-024-00955-y.
2
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans.针对促炎 T 细胞作为一种新的治疗方法，可能解决人类的动脉粥样硬化。
Cell Res. 2024 Jun;34(6):407-427. doi: 10.1038/s41422-024-00945-0. Epub 2024 Mar 15.
3
Adaptive immunity and atherosclerosis.适应性免疫与动脉粥样硬化。
Clin Immunol. 2010 Jan;134(1):33-46. doi: 10.1016/j.clim.2009.07.002. Epub 2009 Jul 26.
4
Dendritic cells in atherosclerosis: evidence in mice and humans.动脉粥样硬化中的树突状细胞：小鼠和人类的证据
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):763-70. doi: 10.1161/ATVBAHA.114.303566. Epub 2015 Feb 12.
5
[Immune cells in atherosclerosis--good or bad?].[动脉粥样硬化中的免疫细胞——有益还是有害？]
Praxis (Bern 1994). 2016 Apr 13;105(8):437-44. doi: 10.1024/1661-8157/a002319.
6
Atherosclerosis antigens as targets for immunotherapy.动脉粥样硬化抗原作为免疫治疗的靶点。
Nat Cardiovasc Res. 2023 Dec;2(12):1129-1147. doi: 10.1038/s44161-023-00376-x. Epub 2023 Dec 11.
7
Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead.树突状细胞和 T 细胞：动脉粥样硬化形成过程中的伙伴及转化的未来之路
Front Immunol. 2020 Jul 29;11:1456. doi: 10.3389/fimmu.2020.01456. eCollection 2020.
8
Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis?共刺激分子在共刺激中的作用及其超越——在动脉粥样硬化中改变平衡？
Thromb Haemost. 2011 Nov;106(5):804-13. doi: 10.1160/TH11-09-0605. Epub 2011 Oct 6.
9
Atherosclerosis: a classic inflammatory disease.动脉粥样硬化：一种经典的炎症性疾病。
Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):817-25. doi: 10.1177/039463201102400401.
10
Obesity, inflammation, and atherosclerosis.肥胖、炎症与动脉粥样硬化。
Nat Rev Cardiol. 2009 Jun;6(6):399-409. doi: 10.1038/nrcardio.2009.55. Epub 2009 Apr 28.
引用本文的文献
1
Association between pan-immune-inflammation value and coronary heart disease in elderly population: a cross-sectional study.老年人群全免疫炎症值与冠心病的关联：一项横断面研究
Front Cardiovasc Med. 2025 Feb 10;12:1538643. doi: 10.3389/fcvm.2025.1538643. eCollection 2025.
本文引用的文献
1
Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells.对配对的人类动脉粥样硬化斑块和血液进行单细胞T细胞受体测序，揭示了扩增的效应T细胞的自身免疫样特征。
Nat Cardiovasc Res. 2023;2(2):112-125. doi: 10.1038/s44161-022-00208-4. Epub 2023 Jan 30.
2
Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis.单细胞RNA分析与T细胞抗原受体谱分析相结合表明动脉粥样硬化中T细胞耐受性检查点的破坏。
Nat Cardiovasc Res. 2023 Mar;2(3):290-306. doi: 10.1038/s44161-023-00218-w. Epub 2023 Feb 23.
3
Peptide Vaccine Against ADAMTS-7 Ameliorates Atherosclerosis and Postinjury Neointima Hyperplasia.抗ADAMTS-7肽疫苗可改善动脉粥样硬化和损伤后内膜增生。
Circulation. 2023 Feb 28;147(9):728-742. doi: 10.1161/CIRCULATIONAHA.122.061516. Epub 2022 Dec 23.
4
Opportunities for an atherosclerosis vaccine: From mice to humans.动脉粥样硬化疫苗的机遇：从老鼠到人。
Vaccine. 2020 Jun 9;38(28):4495-4506. doi: 10.1016/j.vaccine.2019.12.039. Epub 2020 Jan 19.
5
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.免疫检查点抑制剂的不良反应：流行病学、管理和监测。
Nat Rev Clin Oncol. 2019 Sep;16(9):563-580. doi: 10.1038/s41571-019-0218-0.
6
Atherosclerosis.动脉粥样硬化
Circ Res. 2018 Oct 26;123(10):1118-1120. doi: 10.1161/CIRCRESAHA.118.313816.
7
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
Zotero 插件